Buy Bortezomib High quality Bortezomib supplier Bortezomib price CAS NO.179324-69-7
Min.Order / FOB Price:Get Latest Price
| 1 Kilogram |
FOB Price:USD 750.0000 -850.0000 |
- Min.Order :1 Kilogram
- Purity: 98% purity
- Payment Terms : L/C,T/T,Other
Keywords
Wholesale 179324-69-7 Bortezomib used for selective proteasome inhibitor Sale 179324-69- 7 Bortezomib for Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-s 179324-69-7 China suppliers
Quick Details
- Appearance:light yellow solid
- Application:179324-69-7 1>Bortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein
- PackAge:1g;5g;10g;25g;50g;100g;500g;1KG;5KG,25kg,50kg or as customers request
- ProductionCapacity:20|Kilogram|Month
- Storage:Room temperature with sealed well
- Transportation:BY SEA /BY AIR /BY COURIER
Superiority:
1. ISO 9001 approved, GMP producing standard,Proffesional QA system, our quality is guaranteed.
2. Facotory direct sale, most comptive price ensured;
3. Audited Supplier on lookchem, No trick, No Scam!
4. Enough stock can make sure safe delivery.
5. Complete before and after sale service, welcome your questions and glad to help.
C19H25BN4O4
Details:
PRODUCT INFORMATION :
C19H25BN4O4
| Bortezomib Basic information |
| Drug for Cancer treatment |
| Product Name: | Bortezomib |
| Synonyms: | VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;Bortezomib ( Velcade, MG-341, PS-341 ) |
| CAS: | 179324-69-7 |
| MF: | C19H25BN4O4 |
| MW: | 384.24 |
| EINECS: | |
| Product Categories: | Boron Derivatives;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Pepetides;ProteasomeInhibitors;Apis;Inhibitor;Final material;API;peptides |
| Mol File: | 179324-69-7.mol |
|
|
|
| Bortezomib Chemical Properties |
| mp | 122-124°C |
| density | 1.214 |
| storage temp. | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| Stability: | Hygroscopic and Moisture Sensitive |
| CAS DataBase Reference | 179324-69-7(CAS DataBase Reference) |
| Safety Information |
| Hazardous Substances Data | 179324-69-7(Hazardous Substances Data) |
| Bortezomib Usage And Synthesis |
| Drug for Cancer treatment |
Bortezomib is a drug for treatment of hematopoietic malignancies with the appearance being white or white-like crystalline powder. It is easily soluble in dimethyl sulfoxide, ethanol, but insoluble in aqueous solution. This product is the reversible inhibitor of the mammal cell 26S proteasome chymotrypsin-like activity. 26S proteasome is a large protein complex which can degrade ubiquitin. Ubiquitin proteasome pathway plays an important role in regulation of the intracellular concentration of specific proteins in order to maintain the stability of the intracellular environment. Proteolytic affects intracellular multi-level signalling cascade. The disruption of the normal intracellular environment can lead to cell death while the inhibition of the 26S proteasome can prevent the hydrolysis of specific proteins. In vitro tests have proved bortezomib exhibits cytotoxicity to multiple types of cancer cells. The in vivo models of preclinical tumor have proved that bortezomib is capable of delaying the tumor growth of multiple myeloma which is suitable for the treatment of multiple myeloma. The above information is edited by the Chemicalbook of Dai Xiongfeng. |
| Chemical Properties | Yellow Solid |
| Usage | Bortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. T |
| Usage | Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| Usage | selective proteasome inhibitor |
COMPANY INFORMATION :
HenNan sunlake enterprise corporation is located in Henan Province , The central plain of China , Which enjoys favorable geogeaphical position and convenient transportion, The com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .
Sunlake is a professional manufacturer engaged in producing and selling chemicals,including Organic & inorganic chemicals , pigments & Dyestuffs , Water treatment chemicals , Food & FEED additives and others . these products have been being well exported to europe , southeast Asia , the Middle East , Africa , South America and some other countries and areas.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View